Drug Database
Back to search

Netherlands· NL-d9022200a155

Mizollen 10 mg, tabletten met gereguleerde afgifte

A mizolastine product containing mizolastine, registered in Netherlands by Opella Healthcare France S.A.S.. The same ATC class is registered in 7 of our 19 countries.

ATC R06AX25

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMizollen 10 mg, tabletten met geregul…ATCR06AX25REGISTER NO.NL-d9022200a155PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mizolastineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mizolastine is registered in 7 of 19 countries.

Countries holding a registration under ATC R06AX25 (mizolastine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search mizolastine products by name

Mizolastine · ATC R06AX25

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mizolastine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.31 in France to $0.55 in Spain — a ×1.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mizolastine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.55
  • IT Italy$0.42
  • FR France$0.31
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MIZOLASTINE
Manufacturer
Opella Healthcare France S.A.S.
Country
Netherlands (NL)
ATC code
R06AX25
ATC class
Mizolastine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    19982

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mizolastine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mizolastine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Germany · Mizollen
  • France · Mizocler, Mizollen
  • Greece · Oriens
  • Italy · Mizollen, Zolistam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1a3215c2-376a-4816-be62-abde8a01ce17
GET /v1/drugs/1a3215c2-376a-4816-be62-abde8a01ce17?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met gereguleerde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h19982_smpc.pdf",
  "strength": null,
  "atc_label": "Mizolastine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg19982",
  "excipients": [
    "CASTOROLIE, GEHYDROGENEERD",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)"
  ],
  "substances": [
    "MIZOLASTINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h19982.pdf",
  "authorised_at": "1997/04/29",
  "procedure_number": "DE/H/5627/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "19982",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about mizolastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console